Variant position: 74 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 2009 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human DLEAGKNLPFIYGDIPPEMV SEPLEDLDPYYINKKTFIVLN
Mouse DLEAGKNLPFIYGDIPPEMV SEPLEDLDPYYINKKTFIVLN
Rat DLEAGKNLPFIYGDIPPEMV SEPLEDLDPYYINKKTFIVLN
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 2009 Sodium channel protein type 1 subunit alpha
1 – 128 Cytoplasmic
Idiopathic epilepsies with seizures precipitated by fever and SCN1A abnormalities.
Marini C.; Mei D.; Temudo T.; Ferrari A.R.; Buti D.; Dravet C.; Dias A.I.; Moreira A.; Calado E.; Seri S.; Neville B.; Narbona J.; Reid E.; Michelucci R.; Sicca F.; Cross H.J.; Guerrini R.;
Cited for: VARIANTS EIEE6 GLN-101; ILE-322; GLY-356; THR-358; CYS-393; HIS-393; LEU-957; TYR-1414; TRP-1470; ARG-1588; TYR-1608; MET-1630; ARG-1658; ARG-1716; VAL-1783 AND LYS-1787; VARIANTS GEFS+2 PRO-74; ARG-1204 AND SER-1687;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.